Noncovalent scFv multimers of tumor-targeting anti-Lewis(y) hu3S193 humanized antibody.
about
Highly enhanced cytotoxicity of a dimeric bispecific diabody, the hEx3 tetrabody.Cytotoxic enhancement of a bispecific diabody by format conversion to tandem single-chain variable fragment (taFv): the case of the hEx3 diabody.A general chemical synthesis platform for crosslinking multivalent single chain variable fragments.Anti-EGFR scFv tetramer (tetrabody) with a stable monodisperse structure, strong anticancer effect, and a long in vivo half-lifeTumor targeting by a multivalent single-chain Fv (scFv) anti-Lewis Y antibody constructSortase-catalyzed in vitro functionalization of a HER2-specific recombinant Fab for tumor targeting of the plant cytotoxin gelonin.Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systemsMultimerization of anti-(epidermal growth factor receptor) IgG fragments induces an antitumor effect: the case for humanized 528 scFv multimers.Antigen binding and stability properties of non-covalently linked anti-CD22 single-chain Fv dimers.Optimization of the crystallizability of a single-chain antibody fragment.Enhanced Bioactivity of the Anti-LOX-1 scFv Engineered by Multimerization Strategy.Non-Antibody Scaffolds as Alternative Therapeutic AgentsA novel synthetic trivalent single chain variable fragment (tri-scFv) construction platform based on the SpyTag/SpyCatcher protein ligase system
P2860
Q33966998-13E97DEF-DA6F-4DBF-9518-60A21F529243Q34503084-03492545-4D2F-4817-878E-994476E27F29Q35835544-58413AE7-0BAF-4139-A236-4140649C94B0Q36953914-9E825081-113E-4D84-B089-2FB07B7BCEEBQ37146338-C503A721-FCA6-4646-ABBC-069A57510A2BQ37698916-5EDFC9EA-7BBF-4C1F-9C33-CE09C2934E7CQ38885212-274C9BD6-B4B8-47A5-9F09-AF1D1F694E51Q39119871-EAF00658-F8BA-475C-9612-50838FB96181Q40482466-E2104B51-D1DA-4FAE-83E0-0237618405BBQ41718438-14F4C6C4-B946-47B7-9F91-9F3E1C6B3952Q47362764-07899095-080B-410C-B0C7-8D926A6A263DQ57260221-EC2E30D8-AB92-49AA-B415-CC9F6F5FFAF3Q58755125-70B819F8-A538-4EBD-BEBD-22E0523B50C8
P2860
Noncovalent scFv multimers of tumor-targeting anti-Lewis(y) hu3S193 humanized antibody.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Noncovalent scFv multimers of tumor-targeting anti-Lewis
@nl
Noncovalent scFv multimers of tumor-targeting anti-Lewis(y) hu3S193 humanized antibody.
@en
type
label
Noncovalent scFv multimers of tumor-targeting anti-Lewis
@nl
Noncovalent scFv multimers of tumor-targeting anti-Lewis(y) hu3S193 humanized antibody.
@en
prefLabel
Noncovalent scFv multimers of tumor-targeting anti-Lewis
@nl
Noncovalent scFv multimers of tumor-targeting anti-Lewis(y) hu3S193 humanized antibody.
@en
P2093
P2860
P356
P1433
P1476
Noncovalent scFv multimers of tumor-targeting anti-Lewis(y) hu3S193 humanized antibody.
@en
P2093
Alexander A Kortt
Andrew M Scott
Ann M Bayly
Barbara E Power
Deborah R Shapira
Joanne M Caine
John E Burns
Larissa Doughty
Peter J Hudson
Zhanqi Liu
P2860
P304
P356
10.1110/PS.0228503
P577
2003-04-01T00:00:00Z